Both Multiorgan Inflammation and Myeloid Hyperplasia in RelB-Deficient Mice Are T Cell Dependent

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 3974-3979

  Weih, Falk ^a   Durham, Stephen K ^a   Barton, Debra S ^a   Sha, William C ^b   Baltimore, David ^b   Bravo, Rodrigo ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; ONCOPROTEIN; PROTEIN; RAG 1 PROTEIN; RAG-1 PROTEIN; RELB PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELB;

ANIMAL; ARTICLE; B LYMPHOCYTE; BONE MARROW; CROSS BREEDING; GENETICS; HYPERPLASIA; IMMUNE DEFICIENCY; IMMUNOLOGY; INFLAMMATION; MOUSE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SPLENOMEGALY; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; BONE MARROW; CROSSES, GENETIC; HOMEODOMAIN PROTEINS; HYPERPLASIA; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFLAMMATION; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; PROTEINS; PROTO-ONCOGENE PROTEINS; SPLENOMEGALY; T-LYMPHOCYTES; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS;

EID: 0030292678     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Grilli, M., J.-S. Chiu, and M. J. Lenardo. 1993. NF-κB and Rel-participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1.
2. Liou, H.-C., and D. Baltimore, 1993. Regulation of the NF-κB/rel transcription factor and κB inhibitor system. Curr. Opin. Cell Biol. 5:477.
3. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Ann. Rev. Immunol. 12:141.
4. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405.
5. Finco, T. S., and A. S. Baldwin. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3:263.
6. Kopp, E. B., and S. Ghosh. 1995. NF-κB and Rel proteins in innate immunity. Adv. Immunol. 58:1.
7. Miyamoto, S., and I. M. Verma. 1995. The Rel/NF-κB story. Adv. Cancer Res. 66:255.
8. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723.
9. Beg, A. A., W. C. Sha, R. T. Bronson, S. Gosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167.
10. Königen, F., R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965.
11. Sha, W. C., H.-C. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321.
12. H transcription, and Ig class switching. J. Immunol. 156:183.
13. Carrasco, D., R.-P. Ryseck, and R. Bravo. 1993. Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigenpresenting cells. Development 118:1221.
14. Lernbecher, T., U. Müller, and T. Wirth. 1993. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365:767.
15. Lernbecher, T., B. Kistler, and T. Wirth. 1994. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J. 13:4060.
16. Weih, F., D. Carrasco, and R. Bravo. 1994. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen. Oncogene 9:3289.
17. Granelli-Piperno, A., M. Pope, K. Inaba, and R. M. Steinman. 1995. Coexpression of NF-κB/Rel and Sp1 transcription factors in human immunodeficiency virus 1-induced, dendritic cell-T cell syncytia. Proc. Natl. Acad. Sci. USA 92: 10944.
18. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R.-P. Ryseck, S. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331.
19. Burkly, L., C. Hession, L. Ogata, C. Reilly, L. A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373:531.
20. Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou. 1992. RAO-1-deficient mice have no mature B and T lymphocytes. Cell 68:869.
21. Weih, F., R.-P. Ryseck, L. Chen, and R. Bravo. 1996. Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway. Proc. Natl. Acad. Sci. USA 93:5533.
22. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober. 1992. Isolation and fractionation of mononuclear cell populations. In Current Protocols in Immunology. J. Wiley and Sons, eds. Greene Publishing Associates & Wiley-Interscience, New York.
23. Calnan, B. J., S. Szychowski, F. K.-M. Chan, D. Cado, and A. Winoto. 1995. A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity 3:273.
24. 1 gene results in multifocal inflammatory disease. Nature 359:693.
25. 1 knockout mice: a mutation in one cytokine gene causes a dramatic inflammatory disease. Am. J. Pathol. 143:3.
26. Kühn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Müller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263.
27. Dranoff, G., A. D. Crawford, M. Sadelain, B. Ream, A. Rashid, R. T. Bronson, G. R. Dickersin, C. J. Bachurski, E. L. Mark, J. A. Whitsett, and R. C. Mulligan. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264:713.
28. Mombaerts, P., E. Mizoguchi, M. J. Grusby, L. H. Glimcher, A. K. Bahn, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75:275.
29. Strober, W., and R. O. Ehrhardt. 1993. Chronic intestinal inflammation: an unexpected outcome of cytokine or T cell receptor mutant mice. Cell 75:203.
30. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253.
31. Ma, A., M. Datta, E. Margosian, J. Chen, and I. Horak. 1995. T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. J. Exp. Med. 182:1567.
32. Shultz, L. D., and C. L. Sidman. 1987. Genetically determined murine models of immunodeficiency. Annu. Rev. Immunol. 5:367.
33. Shultz, L. D., P. A. Schweitzer, T. V. Rajan, T. Yi, J. N. Ihle, R. J. Matthews, M. L. Thomas, and D. R. Beier. 1993. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445.
34. Tsui, H. W., K. A. Siminovitch, L. de Souza, and F. W. L. Tsui. 1993. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat. Genet. 4:124.
35. Kozlowski, M., I. Mlinaric-Rascan, G.-S. Feng, R. Shen, T. Pawson, and K. A. Siminovitch. 1993. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J. Exp. Med. 178:2157.
36. Yu, C. C. K., H.-W. Tsui, B. Y. Ngan, M. J. Shulman, G. E. Wu, and F. W. L. Tsui. 1996. B and T cells are not required for the viable motheaten phenotype. J. Exp. Med. 183:371.
37. Inaba, K., M. Inaba, M. Deguchi, K. Hagi, R. Yasumizu, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1993. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc. Natl. Acad. Sci. USA 90:3038.